A French study tried lowering 66 HIVers’ doses of the nuke Zerit (d4T) by 10 mg a dose to see if they could keep fighting HIV but avoid the med’s fat-loss and peripheral-neuropathy (nerve damage) side effects. After a year, most had kept their HIV viral loads in check, indicating that lower doses may keep Zerit zipping—without zee extra baggage, bébé.